期刊文献+

2021-2022年度海南省B型Victoria系流感病毒病原学特征分析

Genetic variability of circulating influenza B victoria viruses in Hainan,2021−2022
原文传递
导出
摘要 目的了解2021—2022监测年度海南省B型Victoria系流感病毒的流行状况,分析其抗原性、耐药性和基因变异情况。方法选取33株B型Victoria系流感病毒,利用标准雪貂抗血清进行抗原性分析和荧光法检测病毒对神经氨酸酶抑制剂(NAI)的敏感性,应用Illumina公司MiSeqDx深度测序平台进行基因组序列测定,使用MEGA 10.1.8和DNAStar 7.0.1生物信息学软件进行多序列比对和分析,并采用邻位归并法(N-J)绘制系统进化树。结果2021—2022监测年度海南省流感病毒基因型为B型Victoria系,依据WHO命名方式,33株分离株血凝素(HA)基因和神经氨酸酶(NA)基因均属于1A.3遗传分支,未发生HA与NA基因分支间的重配,与WHO推荐的疫苗株B/Washington/02/2019(2020—2022)抗原性类似,对磷酸奥司他韦敏感,检测到1株NA基因发生D197E氨基酸位点变异并对扎那米韦的敏感性高度降低的毒株。结论2021—2022监测年度海南省流行的B型Victoria系流感病毒与疫苗株相匹配,对神经氨酸酶抑制剂类药物敏感。 Objective In order to understand the prevalence of influenza B virus,the antigenic,resistance to antiviral medications,and genetic characteristics of influenza B viruses circulating in Hainan province during 2021−2022 were analyzed.Methods The antigenic charactetistics of 33 influenza B Victoria lineage viruses were analyzed with reference ferret anti-sera and were tested for neuraminidase inhibitors using a phenotypic assay.The genome of influenza B Victoria lineage viruses were sequenced using the MiSeq™platform(Illumina).Multi-sequence alignment analyses were undertaken using MEGA 10.1.8 and DNAStar 7.0.1.A phylogenetic tree was constructed with the neighbor-joining method.Results The result showed the B Victoria lineage viruses were prevalent in Hainan Province during 2021−2022.The hemagglutinin(HA)and neuraminidase(NA)gene sequences from Hainan circulating viruses were grouped in clade 1A.3,reassortant between HA and NA was not identified.The isolated viruses were antigenically closely related to the recommend vaccine strain B/Washington/02/2019(2020−2022).All 33 viruses were sensitive to Oseltamivir;one viruse had highly reduced sensitivity to Zanamivir with the mutation sites of D197E.Conclusions Overall,the predominant circulating B Victoria lineage viruses in Hainan province during 2021−2022 were matched by current influenza vaccine and have retained susceptibility to neuraminidase inhibitors.
作者 孙初阳 王如敏 唐潆芳 冯芳莉 李丹丹 邱仁 李俊 遇晓杰 Sun Chuyang;Wang Rumin;Tang Yingfang;Feng Fangli;Li Dandan;Qiu Ren;Li Jun;Yu Xiaojie(Hainan Provincial Center for Disease Control and Prevention,Haikou 570203,Hainan,China)
出处 《疾病监测》 CAS CSCD 北大核心 2023年第6期682-688,共7页 Disease Surveillance
关键词 流感病毒 抗原性 神经氨酸酶抑制剂 基因特性 血凝素 Influenza virus Antigenicity Neuraminidase inhibitor Genetic characteristics Hamagglutinin
  • 相关文献

参考文献2

二级参考文献24

  • 1董长颖,韩冰孝.耐药性甲型流感病毒H_3N_2神经氨酸酶免疫原性的研究[J].湖北农业科学,2013,52(3):613-617. 被引量:1
  • 2Paul G W, Schmier J K, Kuehn C M, Ryan K J, Ox- ford J. The burden of influenza B: a structured litera- ture review [-JJ. Am J Public Health, 2013, 103 (3): e43-51.
  • 3Feng L, Shay D K, Jiang Y, Zhou H, Chen X, Zheng Y, Jiang L, Zhang Q, Lin H, Wang S, Ying Y, Xu Y, Wang N, Feng Z, Viboud C, Yang W, Yu H. Influenza -associated mortality in temperate and subtropical Chi- nese cities, 2003-2008[J]. Bull World Health Organ, 2012, 90(4): 279-288.
  • 4Samson M, Pizzorno A, Abed Y, Boivin G. Influenza vi- rus resistance to neuraminidase inhibitors[J]. Antiviral Research, 2013, 98(2) 174-185.
  • 5WHO. Review of the 2013-2014 winter influenza season,nin-neuraminidase with influenza virus neuraminidase [J]. Virol, 1993, 67(6):2972-2980.
  • 6Meijer A, Rebelo-de-Andrade H, Correia V, Besselaar T, Drager-Dayal R, Fry A, Gregory V, Gubareva L, Kageyama T, Laekenby A, Lo J, Odagiri T, Pere- yaslov D, Siqueira M M, Takashita E, Tashiro M, Wang D, Wong S, Zhang W, Daniels R S, Hurt A C. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013[J]. An- tiviral Research, 2014, 110 : 31-41.
  • 7Wang D, Sleeman K, Huang W, Nguyen H T, LevineM, Cheng Y, Li X, Tan M, Xing X, Xu X, Klimov A I, Gubareva L V, Shu Y. Neuraminidase inhibitor sus- ceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir[J]. Antiviral Research, 2013, 97(3) :240-244.
  • 8Bloom J D, Gong L I, Baltimore D. Permissive second- ary mutations enable the evolution of influenza oseltami- vir resistance [J]. Science, 2010, 328(5983): 1272- 1275.
  • 9Sleeman K, Sheu T G, Moore Z, Kilpatrick S, Garg S, Fry A M, Gubareva L V. Influenza B viruses with mu- tation in the neuraminidase active site, North Carolina, USA, 2010-11[J]. Emerg Infect Dis, 2011, 17(11) 2043-2046.
  • 10Hurt A C, Hardie K, Wilson N J, Deng Y M, Oshourn M, Leang S K, Lee R T, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney R C, Xue L, Maurer- Stroh S, Dwyer D E, Wang B, Smith D W, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr I G. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A (H1N1) pdm09 influenza in Australia[J]. J Infect Dis, 2012, 206(2) ,148-157.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部